NCT01937247|CompletedPhase 2/3
Loading search results
Sponsor study identifier
Secondary identifiers
OTHER · AUBMC
interventional
120
1 country
1
Study Start
May 18, 2018
Actual (reported)Primary Completion
October 30, 2020
Actual (reported)Study Completion
October 30, 2020
Actual (reported)The main purpose of the study is to examine whether operating room (OR) efficiency will be improved by significantly decreasing non operative time. This study also aims: 1) to evaluate whether a decrease in non-operative time will result in increased surgeon and staff satisfaction, 2) to determine whether there is an increase in the complication rate during the redesigned process perioperatively and until discharge from the post anesthesia care unit, and 3) to rate patient satisfaction.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 30, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 29, 2013
Actual (reported)September 9, 2013
Actual (reported)May 18, 2018
Actual (reported)October 30, 2020
Actual (reported)October 30, 2020
Actual (reported)Non-operative time
For Group A, non-operative time is defined as induction, emergence and turnover time For Group B, non-operative time is defined as turnover time
within 24 hours of surgery
Satisfaction of the operation room staff and surgeons with the redesigned process
within 24-48 hours after surgery
Patient satisfaction
within 24-48 hours aftery surgery
Complication rate
wihtin 24 hours of srugery
The control group is placebo group and this is our standard practice. Patients will be induced in the operating room and at the end of surgery will be reversed with neostigmine 50µg/kg and glycopyrrolate 10µg/kg. Once extubated and rolled out of the room, the house keeper team will start cleaning the operating room
Patients will be inducted in the induction room. At the end of surgery and after placement of the surgical dressing, the registered nurse will call in the house keeper to start cleaning of the OR (parallel processing) before the patient exits the room. The patient will be reversed with sugammadex 4mg/kg IV
The patients will be inducted in the induction room
The registered nurse will call in the house keeper to start cleaning of the OR (parallel processing) before the patient exits the room
American University of Beirut Medical Center
Beirut, Lebanon
Kaddoum R, Tarraf S, Shebbo FM, Bou Ali A, Karam C, Abi Shadid C, Bouez J, Aouad MT. Reduction of Nonoperative Time Using the Induction Room, Parallel Processing, and Sugammadex: A Randomized Clinical Trial. Anesth Analg. 2022 Aug 1;135(2):406-413. doi: 10.1213/ANE.0000000000006102. Epub 2022 Jun 3.
Roland Kaddoum, MD
American University of Beirut Medical Center
120 participants (actual enrollment reported by the registry).
First Submitted
August 29, 2013
First Posted
September 9, 2013
Study Start
May 18, 2018
Actual (reported)The patient will be reversed with sugammadex 4mg/kg IV, and then extubated before being moved out of the OR
standard process
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
October 30, 2020
Actual (reported)Study Completion
October 30, 2020
Actual (reported)Last Updated
March 9, 2022
Record last verified: 2022-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: